Session

Nocturia: What do we need to know in 2017? Identifying the cause and tailoring the treatment

Industry session by FERRING PHARMACEUTICALS

  • Location:
    Room Vienna, North Hall (Level 1)
  • Chair:
     P.E. Van Kerrebroeck, Maastricht (NL)
  • Aims and objectives of this session

    Do you believe everything about nocturia has been said? Or are you still curious about new developments and insights?
    Debates on nocturia, where new medical evidence will be discussed in a dynamic and interactive way, might be what you’re looking for.
    Join this symposium, where the expert panel will debate and challenge each other and the audience on topics that you are confronted with in daily clinical practice. Don’t miss the most interactive and provocative session at this year’s EAU!

 
Expert panel:
 M.J. Drake, Bristol (GB)
 
 
 J. Rees, Nailsea (GB)
 
 
 P.E. Van Kerrebroeck, Maastricht (NL)
Welcome and opening by the chairman
Debate 1 - Nocturia: Why bother?
Debate 2 - Is treating nocturia easy?
Debate 3 - Are all desmopressin formulations the same?
Take home messages by the chairman